Anil Kane

Anil Kane
Executive Director Global Head of Formulation Sciences

Dr. Kane has more than 25 years of experience in the science and business of taking molecules through the entire drug development process. His extensive knowledge spans early stage development to scale-up and commercial manufacturing, and includes technical transfers between global sites and drug life cycle management. 

In his current role as Executive Director, Dr. Kane leads the formulation group at global sites, provides leadership to all global PDS sites in the complete development of novel lead compounds and line extensions. He works directly with customers to progress their molecules to the next stage of development by helping them to define scientific strategies in early development, clinical development and life cycle management. He is also responsible for evaluating drug delivery technologies to support the business.

Read the interview with Anil Kane, Ph.D, MBA, from Patheon who provides us with the insight into Formulation Development Strategy.

Want to register for 2017 CRO & CMO Seminar?  
Date: 20th June 2017
Location: Hall E2, Meeting Room M17
Time: 10:10 - 15:40 
It's easy: